mAbxience annonce l'approbation par la Commission Européenne des biosimilaires du Denosumab

mAbxience Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom United States of America

View original content:https://www.prnewswire.com/news-releases/mabxience-annonce-lapprobation-par-la-commission-europeenne-des-biosimilaires-du-denosumab-302496765.html